Patients with paediatric-onset IBD and concomitant primary sclerosing cholangitis have substantially worse outcomes, with ...

New recommendations suggest holding back on SGLT2 inhibitors and GLP-1s among those at a lower risk for cardiovascular or ...

The brain’s map of the body remains largely unaffected by amputation, potentially informing phantom limb pain management and ...

New peptide drugs could take aim at a broader range of proteins that cause certain cancers, viral infections, and brain ...

A UK study shows that ADHD in young women increased during the COVID-19 pandemic, peaking in the age group 20-24 years; ...

A phase 3 trial suggests reducing the use of cisplatin when treating nasopharyngeal carcinoma with toripalimab-based ...

A deep-learning analysis of three-dimensional optical coherence tomography scans shows promising accuracy in distinguishing ...

About 23% of MRI scans of the hand or wrist may reveal an incidental finding, and only about 3% overall may need further ...

In nine studies (76 patients), the anti-IgE monoclonal antibody omalizumab (Xolair), given every 2-4 weeks at doses ranging ...

Many doctors adopt damaging lifestyle ‘survival skills’ during residency and keep them for years. Here’s how to spot — and ...

Recently, second-generation anti-VEGF agents, including brolucizumab, faricimab, and 8 mg aflibercept, have become available ...

An extensive analysis shows scant evidence that ketamine or other NMDA receptor agonists reduce chronic noncancer pain but ...